Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma. [electronic resource]
Producer: 20191031Description: 14216 p. digitalISSN:- 2045-2322
- Apoptosis -- drug effects
- Cell Differentiation -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Chemokine CXCL12 -- metabolism
- Humans
- Jurkat Cells
- Lymphoma, T-Cell, Peripheral -- drug therapy
- Phosphorylation -- drug effects
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Receptors, CXCR4 -- metabolism
- Signal Transduction -- drug effects
- T-Lymphocytes, Helper-Inducer -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.